Table 1.
The patient characteristics.
Fig 1.
FcγRIIb expression and localization in liver tissues of patients.
Representative light microscopic images of patients who were diagnosed as NASH (a: NAS, 2; b: NAS, 8). FcγRIIb signals detected with DAB (brown) are distributed in LSECs. In b, arrowheads indicate LSECs that do not detect FcγRIIb signals. Nuclei were counterstained with hematoxylin (blue). Scale bars represent 100 μm.
Fig 2.
Correlation with biological indexes and biochemical data.
Scatter plots show the correlation of FcγRIIb expression levels with BMI, Plt, and serum biochemical data. Statistical correlation was analyzed by the Pearson correlation coefficient test. #: one outlier (indicated as ◇ in γ-GTP diagram) removed. *: small correlation by the Pearson correlation coefficient test (R<-0.3). **: medium correlation by the Pearson correlation coefficient test (R<-0.4).
Fig 3.
Comparisons of diagnosis, sex, and pathological scores.
Box plots show FcγRIIb expression levels. Lines inside the boxes denote medians, the boxes represent the interquartile range, and whiskers extend to the minimum and maximum. The statistical differences among groups are analyzed by the Mann-Whitney or the Kruskal-Wallis test. A P-value <0.05 was considered to be significant.